Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 14 (PPIAP14)

Target
PPIAP14
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA)-related gene
01

Overview

Peptidylprolyl isomerase A pseudogene 14 (PPIAP14) is a human pseudogene, meaning it is a genomic DNA sequence similar to the functional PPIA gene but does not produce a functional protein. Pseudogenes like PPIAP14 are typically considered non-coding and do not have an enzymatic, structural, or receptor function. Some PPIA pseudogenes can regulate gene expression as long non-coding RNAs, for example by acting as competing endogenous RNAs (ceRNAs) to regulate PPIA mRNA indirectly, but this has been specifically described only for other pseudogenes such as PPIAP22. There is currently no evidence that PPIAP14 serves as a therapeutic target or plays a direct role in disease. PPIAP14 is not a gene encoding a receptor, enzyme, transporter, or other classical drug target class. It is a pseudogene, most likely non-functional at the protein level, with no established biological or disease role, drug interactions, mechanisms of action, or biomarker utility reported as of now. For pharmacological or target discovery purposes, PPIAP14 is not considered actionable.

Other names
Peptidylprolyl isomerase A pseudogene 14PPIAP14
02

Biological functions

No direct protein-coding functionMay have regulatory RNA function by analogy with other PPIA pseudogenes, which can interact with microRNAs to regulate parental gene expression
03

Disease associations

Potential regulatory roles in gene expression by analogy with other PPIA pseudogenes, but no direct evidence or disease association for PPIAP14 itself found in current literature

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 14 (PPIAP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 14 (PPIAP14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call